759 results on '"Sattler, Martin"'
Search Results
52. Supplementary Table 3 from Paxillin Is a Target for Somatic Mutations in Lung Cancer: Implications for Cell Growth and Invasion
53. A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision Medicine
54. Exploring the Next Frontier in Non–Small-Cell Lung Cancer With High MET and Mutated Epidermal Growth Factor Receptor
55. LSD1-targeted therapy—a multi-purpose key to unlock immunotherapy in small cell lung cancer
56. The role of primary health care in long-term care facilities during the COVID-19 pandemic in 30 European countries: a retrospective descriptive study (Eurodata study)
57. Identification of novel therapeutic targets in acute leukemias with NRAS mutations using a pharmacologic approach
58. Correction: Evaluation of ERK as a therapeutic target in acute myelogenous leukemia
59. Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
60. Targeting Mcl-1 for multiple myeloma (MM) therapy: Drug-induced generation of Mcl-1 fragment Mcl-1128–350 triggers MM cell death via c-Jun upregulation
61. Effect of tree shelters on the survival and growth of coniferous tree species in Central South Bulgaria
62. Anti‐SARS‐CoV‐2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID‐19 therapy
63. Effect of tree shelters on the survival and growth of coniferous tree species in Central South Bulgaria
64. Therapeutic Targeting of the Receptor Tyrosine Kinase Met
65. Mutated Tyrosine Kinases As Therapeutic Targets In Myeloid Leukemias
66. Rac2-MRC-cIII–generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors
67. YAP1 maintains active chromatin state in head and neck squamous cell carcinomas that promotes tumorigenesis through cooperation with BRD4
68. Correction: Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer
69. EFFECT OF TREE SHELTERS ON THE SURVIVAL AND GROWTH OF DECIDUOUS TREE SPECIES IN NORTH-WESTERN BULGARIA
70. Functional Screening Identifies CRLF2 in Precursor B-Cell Acute Lymphoblastic Leukemia
71. Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural Mesothelioma
72. The Small-Molecule VEGF Receptor Inhibitor Pazopanib (GW786034B) Targets Both Tumor and Endothelial Cells in Multiple Myeloma
73. Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers
74. Anti‐SARS‐CoV‐2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID‐19 therapy.
75. Combined Targeting of Distinct c-Myc and JunB Transcriptional Programs Inducing Synergistic Anti-Myeloma Activity
76. Biomechanical Performance of BoneHelix® Compared with Elastic Stable Intramedullary Nailing (ESIN) in a Pediatric Tibia Fracture Model
77. OAB-030: Combined targeting of distinct c-Myc and JunB transcriptional programs induces synergistic anti-myeloma activity
78. Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications
79. BCR-ABL promotes the frequency of mutagenic single-strand annealing DNA repair
80. Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2
81. Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer
82. a case vignette study in 31 countries
83. The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes
84. c-Met and hepatocyte growth factor: Potential as novel targets in cancer therapy
85. CO2 emission reduction in the cement industry by using a solar calciner
86. Vom Materiallieferanten zum Lösungsanbieter
87. Co-stimulatory and co-inhibitory immune markers in solid tumors with MET alterations
88. Superoxide-dependent and -independent mitochondrial signaling during apoptosis in multiple myeloma cells
89. Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells
90. Mechanisms of Transformation by the BCR/ABL Oncogene
91. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571
92. Der Öffentlichkeitsanspruch der Kirchen nach 1945 in Deutschland. Erinnerungen an die Anfänge einer religionspolitologischen Grundlegung des Verhältnisses von Religion und Politik
93. Impact of collagen crosslinking on the second harmonic generation signal and the fluorescence lifetime of collagen autofluorescence
94. Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility
95. Gibt es eine Wissenschaft ohne Geist?
96. The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications
97. Inhibitors of the Transcription Factor STAT3 Decrease Growth and Induce Immune Response Genes in Models of Malignant Pleural Mesothelioma (MPM)
98. Multi‐wavelength, handheld laser speckle imaging for skin evaluation
99. The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping
100. Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell lines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.